NPM1 and acute myeloid leukemia: Considering that NPM1-mutated AML represents the largest subgroup of AML and is classified as being of standard risk, the detection of persistent residual NPM1-mutated transcripts may provide additional guidelines for decision making between chemotherapy and hematopoietic cell transplantation.